Imaging the etiology of apathy, anxiety, and depression in Parkinson’s disease: implication for treatment S Thobois, S Prange, V Sgambato-Faure, L Tremblay, E Broussolle Current neurology and neuroscience reports 17, 1-8, 2017 | 116 | 2017 |
Age and time course of long-term motor and nonmotor complications in Parkinson disease S Prange, T Danaila, C Laurencin, C Caire, E Metereau, H Merle, ... Neurology 92 (2), e148-e160, 2019 | 90 | 2019 |
Depression in patients with Parkinson’s disease: current understanding of its neurobiology and implications for treatment S Prange, H Klinger, C Laurencin, T Danaila, S Thobois Drugs & Aging 39 (6), 417-439, 2022 | 81 | 2022 |
Early limbic microstructural alterations in apathy and depression in de novo Parkinson's disease S Prange, E Metereau, A Maillet, E Lhommée, H Klinger, P Pelissier, ... Movement Disorders 34 (11), 1644-1654, 2019 | 74 | 2019 |
Serotonergic and dopaminergic lesions underlying parkinsonian neuropsychiatric signs A Maillet, E Météreau, L Tremblay, E Favre, H Klinger, E Lhommée, ... Movement Disorders 36 (12), 2888-2900, 2021 | 48 | 2021 |
What a neurologist should know about PET and SPECT functional imaging for parkinsonism: a practical perspective S Thobois, S Prange, C Scheiber, E Broussolle Parkinsonism & related disorders 59, 93-100, 2019 | 44 | 2019 |
Structural imaging in Parkinson’s disease: new developments S Prange, E Metereau, S Thobois Current Neurology and Neuroscience Reports 19, 1-13, 2019 | 40 | 2019 |
Imaging the limbic system in Parkinson’s disease—a review of limbic pathology and clinical symptoms M Banwinkler, H Theis, S Prange, T van Eimeren Brain sciences 12 (9), 1248, 2022 | 38 | 2022 |
Limbic stimulation drives mania in STN‐DBS in Parkinson disease: a prospective study S Prange, Z Lin, M Nourredine, T Danaila, C Laurencin, ... Annals of Neurology 92 (3), 411-417, 2022 | 17 | 2022 |
Limbic serotonergic plasticity contributes to the compensation of apathy in early Parkinson's disease S Prange, E Metereau, A Maillet, H Klinger, E Schmitt, E Lhommée, ... Movement disorders 37 (6), 1211-1221, 2022 | 16 | 2022 |
Molecular Imaging in Parkinsonian Disorders—What’s New and Hot? S Prange, H Theis, M Banwinkler, T van Eimeren Brain Sciences 12 (9), 1146, 2022 | 14 | 2022 |
Historical crossroads in the conceptual delineation of apathy in Parkinson’s disease S Prange, J Pagonabarraga, P Krack, J Kulisevsky, V Sgambato, ... Brain 141 (2), 613-619, 2018 | 12 | 2018 |
Motivational and cognitive predictors of apathy after subthalamic nucleus stimulation in Parkinson’s disease M Béreau, A Kibleur, M Servant, G Clément, K Dujardin, AS Rolland, ... Brain 147 (2), 472-485, 2024 | 7 | 2024 |
Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson’s disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial C Laurencin, N Timestit, A Marques, DD Duchez, C Giordana, S Meoni, ... Journal of Neurology 270 (10), 4851-4859, 2023 | 6 | 2023 |
Noninvasive electrical stimulation for psychiatric care in Down syndrome J Brunelin, O Adam, E Favre, S Prange, E Zante, C Demily Brain Stimulation: Basic, Translational, and Clinical Research in …, 2022 | 6 | 2022 |
Imagerie cérébrale dans les syndromes parkinsoniens S Prange, M Hermier, T Danaila, C Laurencin, S Thobois La Presse Médicale 46 (2), 202-209, 2017 | 5 | 2017 |
Impulsive-compulsive behaviour in early Parkinson’s disease is determined by apathy and dopamine receptor D3 polymorphism H Theis, S Prange, GN Bischof, MC Hoenig, M Tittgemeyer, ... npj Parkinson's Disease 9 (1), 154, 2023 | 4 | 2023 |
Utilisation de l’imagerie cérébrale dans notre pratique face à un syndrome parkinsonien S Prange, S Thobois Pratique Neurologique-FMC 11 (2), 135-141, 2020 | 2 | 2020 |
Amantadine use in the French prospective NS-Park cohort M Fabbri, V Rousseau, JC Corvol, A Sommet, F Tubach, Y De Rycke, ... Journal of Neural Transmission, 1-13, 2024 | 1 | 2024 |
Imaging of impulse control disorders in Parkinson's disease S Prange, S Thobois Revue Neurologique, 2024 | | 2024 |